ID   TNFL4_HUMAN             Reviewed;         183 AA.
AC   P23510; Q5JZA5; Q9HCN9;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1991, sequence version 1.
DT   21-MAR-2012, entry version 104.
DE   RecName: Full=Tumor necrosis factor ligand superfamily member 4;
DE   AltName: Full=Glycoprotein Gp34;
DE   AltName: Full=OX40 ligand;
DE            Short=OX40L;
DE   AltName: Full=TAX transcriptionally-activated glycoprotein 1;
DE   AltName: CD_antigen=CD252;
GN   Name=TNFSF4; Synonyms=TXGP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=91141479; PubMed=1996093;
RA   Miura S., Ohtani K., Numata N., Niki M., Ohbo K., Ina Y., Gojobori T.,
RA   Tanaka Y., Tozawa H., Nakamura M., Sugamura K.;
RT   "Molecular cloning and characterization of a novel glycoprotein, gp34,
RT   that is specifically induced by the human T-cell leukemia virus type I
RT   transactivator p40tax.";
RL   Mol. Cell. Biol. 11:1313-1325(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=94321936; PubMed=7913952; DOI=10.1084/jem.180.2.757;
RA   Godfrey W.R., Fagnoni F.F., Harara M.A., Buck D., Engleman E.G.;
RT   "Identification of a human OX-40 ligand, a costimulator of CD4+ T
RT   cells with homology to tumor necrosis factor.";
RL   J. Exp. Med. 180:757-762(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-67.
RX   MEDLINE=21069360; PubMed=11197696; DOI=10.1038/sj.gene.6363709;
RA   Hikami K., Tsuchiya N., Tokunaga K.;
RT   "New variations in human OX40 ligand (CD134L) gene.";
RL   Genes Immun. 1:521-522(2000).
RN   [6]
RP   CHARACTERIZATION.
RX   MEDLINE=94357171; PubMed=8076595;
RA   Baum P.R., Gayle R.B. III, Ramsdell F., Srinivasan S., Sorensen R.A.,
RA   Watson M.L., Seldin M.F., Baker E., Sutherland G.R., Clifford K.N.,
RA   Alderson M.R., Goodwin R.G., Fanslow W.C.;
RT   "Molecular characterization of murine and human OX40/OX40 ligand
RT   systems: identification of a human OX40 ligand as the HTLV-1-regulated
RT   protein gp34.";
RL   EMBO J. 13:3992-4001(1994).
RN   [7]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO SLE.
RX   PubMed=18059267; DOI=10.1038/ng.2007.47;
RA   Cunninghame Graham D.S., Graham R.R., Manku H., Wong A.K.,
RA   Whittaker J.C., Gaffney P.M., Moser K.L., Rioux J.D., Altshuler D.,
RA   Behrens T.W., Vyse T.J.;
RT   "Polymorphism at the TNF superfamily gene TNFSF4 confers
RT   susceptibility to systemic lupus erythematosus.";
RL   Nat. Genet. 40:83-89(2008).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.41 ANGSTROMS) OF 48-183 IN COMPLEX WITH
RP   TNFRSF4, SUBUNIT, DISULFIDE BOND, AND GLYCOSYLATION AT ASN-152.
RX   PubMed=16905106; DOI=10.1016/j.str.2006.06.015;
RA   Compaan D.M., Hymowitz S.G.;
RT   "The crystal structure of the costimulatory OX40-OX40L complex.";
RL   Structure 14:1321-1330(2006).
CC   -!- FUNCTION: Cytokine that binds to TNFRSF4. Co-stimulates T-cell
CC       proliferation and cytokine production.
CC   -!- SUBUNIT: Homotrimer.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type II membrane
CC       protein.
CC   -!- INDUCTION: By HTLV-1 transactivator p40-Tax.
CC   -!- DISEASE: Genetic variations in TNFSF4 influence susceptibility to
CC       systemic lupus erythematosus (SLE) [MIM:152700]. SLE is a chronic,
CC       inflammatory and often febrile multisystemic disorder of
CC       connective tissue. It affects principally the skin, joints,
CC       kidneys and serosal membranes. It is thought to represent a
CC       failure of the regulatory mechanisms of the autoimmune system.
CC       Note=The upstream region of TNFSF4 contains a single risk
CC       haplotype for SLE, which is correlated with increased expression
CC       of both cell-surface TNFSF4 and TNFSF4 transcripts. Increased
CC       levels of TNFSF4 are thought to augment T-cell-APC interaction and
CC       the functional consequences of T-cell activation, thereby
CC       destabilizing peripheral tolerance.
CC   -!- SIMILARITY: Belongs to the tumor necrosis factor family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA18438.2; Type=Erroneous gene model prediction;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D90224; BAA14259.1; -; mRNA.
DR   EMBL; X79929; CAA56284.1; -; mRNA.
DR   EMBL; AL022310; CAA18438.2; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL022310; CAI20416.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW90938.1; -; Genomic_DNA.
DR   EMBL; AB042988; BAB18304.1; -; Genomic_DNA.
DR   IPI; IPI00011974; -.
DR   PIR; A39680; A39680.
DR   RefSeq; NP_003317.1; NM_003326.3.
DR   UniGene; Hs.181097; -.
DR   PDB; 2HEV; X-ray; 2.41 A; F=51-183.
DR   PDBsum; 2HEV; -.
DR   ProteinModelPortal; P23510; -.
DR   SMR; P23510; 58-183.
DR   DIP; DIP-3023N; -.
DR   STRING; P23510; -.
DR   DMDM; 121540; -.
DR   PRIDE; P23510; -.
DR   DNASU; 7292; -.
DR   Ensembl; ENST00000281834; ENSP00000281834; ENSG00000117586.
DR   GeneID; 7292; -.
DR   KEGG; hsa:7292; -.
DR   UCSC; uc001giw.1; human.
DR   CTD; 7292; -.
DR   GeneCards; GC01M173152; -.
DR   H-InvDB; HIX0023642; -.
DR   HGNC; HGNC:11934; TNFSF4.
DR   MIM; 152700; phenotype.
DR   MIM; 603594; gene.
DR   neXtProt; NX_P23510; -.
DR   PharmGKB; PA36625; -.
DR   eggNOG; NOG47572; -.
DR   GeneTree; ENSGT00390000015127; -.
DR   HOGENOM; HBG125858; -.
DR   HOVERGEN; HBG056457; -.
DR   InParanoid; P23510; -.
DR   KO; K05469; -.
DR   OMA; YPPIQSI; -.
DR   OrthoDB; EOG4K3KXF; -.
DR   PhylomeDB; P23510; -.
DR   NextBio; 28511; -.
DR   ArrayExpress; P23510; -.
DR   Bgee; P23510; -.
DR   CleanEx; HS_TNFSF4; -.
DR   Genevestigator; P23510; -.
DR   GermOnline; ENSG00000117586; Homo sapiens.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral to plasma membrane; NAS:BHF-UCL.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0002526; P:acute inflammatory response; ISS:BHF-UCL.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IDA:BHF-UCL.
DR   GO; GO:0071380; P:cellular response to prostaglandin E stimulus; IDA:BHF-UCL.
DR   GO; GO:0071954; P:chemokine (C-C motif) ligand 11 production; ISS:BHF-UCL.
DR   GO; GO:0002215; P:defense response to nematode; ISS:BHF-UCL.
DR   GO; GO:0035708; P:interleukin-4-dependent isotype switching to IgE isotypes; ISS:BHF-UCL.
DR   GO; GO:0035709; P:memory T cell activation; ISS:BHF-UCL.
DR   GO; GO:0032689; P:negative regulation of interferon-gamma production; ISS:BHF-UCL.
DR   GO; GO:0032700; P:negative regulation of interleukin-17 production; IDA:BHF-UCL.
DR   GO; GO:0045590; P:negative regulation of regulatory T cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL.
DR   GO; GO:0045626; P:negative regulation of T-helper 1 cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-dependent; ISS:BHF-UCL.
DR   GO; GO:0046641; P:positive regulation of alpha-beta T cell proliferation; ISS:BHF-UCL.
DR   GO; GO:0050871; P:positive regulation of B cell activation; ISS:BHF-UCL.
DR   GO; GO:0002891; P:positive regulation of immunoglobulin mediated immune response; ISS:BHF-UCL.
DR   GO; GO:0051024; P:positive regulation of immunoglobulin secretion; ISS:BHF-UCL.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IDA:BHF-UCL.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; IDA:BHF-UCL.
DR   GO; GO:0032733; P:positive regulation of interleukin-10 production; ISS:BHF-UCL.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL.
DR   GO; GO:0032736; P:positive regulation of interleukin-13 production; ISS:BHF-UCL.
DR   GO; GO:0032753; P:positive regulation of interleukin-4 production; IDA:BHF-UCL.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL.
DR   GO; GO:0043382; P:positive regulation of memory T cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0002726; P:positive regulation of T cell cytokine production; ISS:BHF-UCL.
DR   GO; GO:0045630; P:positive regulation of T-helper 2 cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0002830; P:positive regulation of type 2 immune response; ISS:BHF-UCL.
DR   GO; GO:0009615; P:response to virus; ISS:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0035712; P:T-helper 2 cell activation; ISS:BHF-UCL.
DR   InterPro; IPR006052; TNF.
DR   InterPro; IPR021184; TNF_CS.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like.
DR   Pfam; PF00229; TNF; 1.
DR   SMART; SM00207; TNF; 1.
DR   SUPFAM; SSF49842; TNF_like; 1.
DR   PROSITE; PS00251; TNF_1; 1.
DR   PROSITE; PS50049; TNF_2; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytokine; Disulfide bond;
KW   Glycoprotein; Membrane; Reference proteome; Signal-anchor;
KW   Systemic lupus erythematosus; Transmembrane; Transmembrane helix.
FT   CHAIN         1    183       Tumor necrosis factor ligand superfamily
FT                                member 4.
FT                                /FTId=PRO_0000185493.
FT   TOPO_DOM      1     23       Cytoplasmic (Potential).
FT   TRANSMEM     24     50       Helical; Signal-anchor for type II
FT                                membrane protein; (Potential).
FT   TOPO_DOM     51    183       Extracellular (Potential).
FT   CARBOHYD     90     90       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    114    114       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    152    152       N-linked (GlcNAc...).
FT   CARBOHYD    157    157       N-linked (GlcNAc...) (Potential).
FT   DISULFID     97    181
FT   STRAND       61     70
FT   TURN         71     73
FT   STRAND       74     78
FT   STRAND       92     94
FT   STRAND       99    120
FT   STRAND      126    143
FT   STRAND      148    155
FT   STRAND      165    174
SQ   SEQUENCE   183 AA;  21050 MW;  0D5604AD29D529CF CRC64;
     MERVQPLEEN VGNAARPRFE RNKLLLVASV IQGLGLLLCF TYICLHFSAL QVSHRYPRIQ
     SIKVQFTEYK KEKGFILTSQ KEDEIMKVQN NSVIINCDGF YLISLKGYFS QEVNISLHYQ
     KDEEPLFQLK KVRSVNSLMV ASLTYKDKVY LNVTTDNTSL DDFHVNGGEL ILIHQNPGEF
     CVL
//
